Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo

•Inclusion Criteria: Sexe: female and male; * Age: over 18 years old; * Patients with stable non-segmental vitiligo lesions (defined as no new lesions or lesions that have been present for at least 3 months, lack of hypochromic margins in Wood's lumen and absence of confetti depigmentation); * Patients with 2 to 6 symmetrical lesions (1 to 3 on each side). These lesions (macules) will be treated for a minimum surface of 2 cm² and a maximum surface of 100 cm². * Healthy volunteer; * Volunteer having given in writing his free, informed and express consent; * Volunteer willing to abide by the protocol and procedures of the study. Exclusion Criteria: * Pregnant woman or woman who is breastfeeding or planning for early pregnancy during the study; * Patient with segmental or mixed vitiligo; * Patient with vitiligo of the external genitalia; * Patient with vitiligo touching hands and feet only * Patient with a history of skin cancer or pre-cancerous skin lesions; * Patient taking topical or systemic vitiligo treatments in the month prior to the start of the study; * Patient taking concomitant local or general corticosteroid therapy or immunomodulatory therapy; * Patient with a history of photodermatoses or taking photosensitizing medications; * Patient having planned to expose himself (artificial sun or UV) during the study at the level of the zones to be treated and / or having been exposed during the month preceding the beginning of the study and having an acquired pigmentation (tanning) obvious; * Patient who had been treated with phototherapy within 4 weeks before randomization; * Patient with lithium allergy.